Furthermore, compared with normal tissues, RPLP0, RPLP1and RPLP2 are significantly up-regulated in gynecologic tumors such as ovarian and endometrial cancers, suggesting that these proteins can be used as specific prognostic markers and related therapeutic targets for gynecological tumors [98]. Here, RPLP0 is linked to endometrial cancer.